These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

775 related items for PubMed ID: 6192963

  • 1. Management of breast cancer.
    Cohen IA, Keller JH, Abate MA.
    Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiestrogen treatment of breast cancer: an overview.
    Pearson OH, Manni A, Arafah BM.
    Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
    [Abstract] [Full Text] [Related]

  • 4. [Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer].
    Szepesi T, Schratter-Sehn AU.
    Wien Klin Wochenschr; 1982 Sep 17; 94(17):463-9. PubMed ID: 6760557
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Hormone therapy of patients with breast cancer].
    Moiseenko VM, Semiglazov VF.
    Vopr Onkol; 1984 Sep 17; 30(11):3-9. PubMed ID: 6393574
    [No Abstract] [Full Text] [Related]

  • 8. Endocrine therapy of breast and prostate cancer.
    Manni A.
    Endocrinol Metab Clin North Am; 1989 Jun 17; 18(2):569-92. PubMed ID: 2663486
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endocrine management of breast cancer.
    Schneider PG, Jackisch C, Brandt B.
    Int J Fertil Menopausal Stud; 1994 Jun 17; 39 Suppl 2():115-27. PubMed ID: 7874188
    [Abstract] [Full Text] [Related]

  • 14. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P.
    Clin Cancer Res; 1995 Feb 17; 1(2):189-98. PubMed ID: 9815973
    [Abstract] [Full Text] [Related]

  • 15. [Chemical adrenalectomy induced by aminoglutethimide in the treatment of breast cancer. A review].
    Cikes M.
    Schweiz Med Wochenschr; 1983 Mar 19; 113(11):382-91. PubMed ID: 6342129
    [Abstract] [Full Text] [Related]

  • 16. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
    Nesković-Konstantinović ZB, Nikolić-Vukosavljević DB, Branković-Magić MV, Mitrovic LB, Spuzić I.
    Neoplasma; 2000 Mar 19; 47(2):107-13. PubMed ID: 10985476
    [Abstract] [Full Text] [Related]

  • 17. The use of endocrine therapy.
    Pritchard KI, Sutherland DJ.
    Hematol Oncol Clin North Am; 1989 Dec 19; 3(4):765-805. PubMed ID: 2481670
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Response of patients with carcinoma of the breast to hormonal therapy and combination chemotherapy.
    Henderson MD, Buroker TR, Samson MK, Mood DW, Baker LH, Vaitkevicius VK.
    Surg Gynecol Obstet; 1975 Aug 19; 141(2):232-4. PubMed ID: 1154233
    [Abstract] [Full Text] [Related]

  • 20. [The state of hormone and chemotherapy in breast neoplasms].
    Brunner KW.
    Schweiz Med Wochenschr; 1978 Sep 02; 108(35):1338-50. PubMed ID: 210499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.